Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)
 
 • Company Description   
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

Number of Employees: 2,670

 
 • Price / Volume Information   
Yesterday's Closing Price: $35.93 Daily Weekly Monthly
20 Day Moving Average: 1,657,521 shares
Shares Outstanding: 96.31 (millions)
Market Capitalization: $3,460.56 (millions)
Beta: 1.24
52 Week High: $129.09
52 Week Low: $26.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.70% 7.18%
12 Week -40.87% -36.32%
Year To Date -61.53% -53.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13011 McCallen Pass Building A Suite 100
-
Austin,TX 78753
USA
ph: 650-249-9090
fax: -
mbrophy@natera.com http://www.natera.com
 
 • General Corporate Information   
Officers
Steve Chapman - Chief Executive Officer and President
Matthew Rabinowitz - Executive Chairman
Michael Brophy - Chief Financial Officer
Jonathan Sheena - Director
Roy Baynes - Director

Peer Information
Natera, Inc. (CHCR)
Natera, Inc. (ESRX)
Natera, Inc. (MYDP)
Natera, Inc. (GBCS)
Natera, Inc. (LAXAF)
Natera, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 632307104
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 96.31
Most Recent Split Date: (:1)
Beta: 1.24
Market Capitalization: $3,460.56 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.46 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-5.80 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.38
Price/Cash Flow: -
Price / Sales: 5.19
EPS Growth
vs. Year Ago Period: -95.95%
vs. Previous Quarter: 2.03%
Sales Growth
vs. Year Ago Period: 27.45%
vs. Previous Quarter: 12.22%
ROE
03/31/22 - -96.99
12/31/21 - -90.55
09/30/21 - -85.05
ROA
03/31/22 - -48.12
12/31/21 - -43.97
09/30/21 - -40.89
Current Ratio
03/31/22 - 4.24
12/31/21 - 4.99
09/30/21 - 5.96
Quick Ratio
03/31/22 - 4.13
12/31/21 - 4.87
09/30/21 - 5.82
Operating Margin
03/31/22 - -81.90
12/31/21 - -75.43
09/30/21 - -72.15
Net Margin
03/31/22 - -81.90
12/31/21 - -75.43
09/30/21 - -72.15
Pre-Tax Margin
03/31/22 - -81.79
12/31/21 - -75.32
09/30/21 - -72.03
Book Value
03/31/22 - 5.63
12/31/21 - 6.91
09/30/21 - 8.09
Inventory Turnover
03/31/22 - 13.09
12/31/21 - 11.90
09/30/21 - 11.35
Debt-to-Equity
03/31/22 - 0.52
12/31/21 - 0.43
09/30/21 - 0.37
Debt-to-Capital
03/31/22 - 34.11
12/31/21 - 30.03
09/30/21 - 26.95
 

Powered by Zacks Investment Research ©